Department Of OB/GYN
Investigator
Jason Wright, MD
Email
jw2459@cumc.columbia.edu
Dr. Wright completed residency and a fellowship in Gynecologic Oncology at Washington University in St. Louis. He is board-certified in Obstetrics and Gynecology and Gynecologic Oncology. Dr. Wright sees women with all gynecologic cancers and has extensive training in minimally invasive surgery, extended pelvic resections, and pelvic reconstructive surgery. Dr. Wright also cares for a large number of women with hereditary cancer syndromes. In addition, Dr. Wright sees women with who require complex gynecologic procedures.

Dr. Wright is an internationally recognized expert in the treatment of gynecologic cancers and gynecologic surgery. He has authored over 600 articles, chapters, and textbooks. A major focus of Dr. Wright's work is the delivery of quality care to patients with cancer and the improvement of outcomes for patients with gynecologic cancer. Dr. Wright's primary clinical research focuses on the evaluation of novel therapeutics and the early detection and prevention of gynecologic cancer. Dr. Wright is the principal investigator on a number of clinical trials. He currently serves as Editor-in-Chief of Obstetrics & Gynecology, a leading academic journal in the field.

Clinical Studies Managed By This Investigator:
Condition Study Title
Gynecologic Cancer [ CLOSED ] A study for patients with ovarian cancer using biomarker HE-4 to predict recurrence
Gynecologic Cancer [ CLOSED ] A study for patients with cancer of the ovary, fallopian tube, or primary peritoneal cancer using study drug AZD1775
Gynecologic Cancer [ CLOSED ] A study for women with ovarian cancer using study drug farletuzumab
Gynecologic Cancer [ CLOSED ] CONCERTO: Study of combination tablets in women with recurrent platinum resistant epithelian ovarian cancer
Gynecologic Cancer [ CLOSED ] Study of Drug in Patients with Endometrioid Ovarian, Fallopian Tube, or Primary Peritoneal Cancer who Have Received Prior Chemotherapy
Cancer [ CLOSED ] Study of New Drug Combination in Patients with Newly-Diagnosed Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Gynecologic Cancer [ CLOSED ] Study of Drug in Patients with Recurrent, Persistent or Metastatic Cervical Cancer
Gynecologic Cancer [ CLOSED ] Evaluation of Fallopian Tube Cell Samples Collected by MAKO 7
Gynecologic Cancer [ CLOSED ] Study of CA 125 and HE4 Serum Biomarkers in Women with Ovarian, Fallopian Tube, or Primary Peritoneal Cancers (Excluding Ovarian Tumors)
Gynecologic Cancer [ CLOSED ] Study of Pembrolizumab Plus Chemotherapy versus Chemotherapy Plus Placebo in Patients with Cervical Cancer
Gynecologic Cancer [ CLOSED ] Study of Cobimetinib with Niraparib, With or Without Atezolizumab, in Patients with Advanced Platinum-Sensitive Ovarian Cancer
Obstetrics & Gynecology [ CLOSED ] Study of Pembrolizumab in Combination with Chemotherapy for Patients with Endometrial Cancer
Gynecologic Cancer [ CLOSED ] Study of Upifitamab Rilsodotin (XMT-1536) in Patients with Recurrent Ovarian Cancer
Gynecologic Cancer Comparing Investigational Surgery to Laparotomy After Chemotherapy in Women with Epithelial Ovarian Cancer (EOC)
Gynecologic Cancer Comparing Surgeries to Reduce the Risk of Ovarian Cancer in Women with BRCA1 Mutations
Gynecologic Cancer [ CLOSED ] Study of Abemaciclib in Combination with Letrozole in Women with Endometrial Cancer